Series B - Abbisko Therapeutics - Mar 21, 2019 Funding Round Profile - Cointime

Bitcoin $98,815.57 -0.22%
Ethereum $3,349.31 -0.70%
BNB $652.16 +3.55%
Optimism $2.20 +7.15%
Arbitrum $0.83 +4.92%
Solana $260.12 +0.38%
Polygon $0.54 +16.16%
Cosmos $7.88 +19.67%
Avalanche $43.66 +20.81%

Bitcoin $98,815.57 -0.22%
Ethereum $3,349.31 -0.70%
BNB $652.16 +3.55%
Optimism $2.20 +7.15%
Arbitrum $0.83 +4.92%
Solana $260.12 +0.38%
Polygon $0.54 +16.16%
Cosmos $7.88 +19.67%
Avalanche $43.66 +20.81%

Abbisko Therapeutics

company

Funding Round

Series B

Money Raised

$ 42M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 7, 2017	Series A	$ 28M	Lilly Asia Ventures	Detail